6 documents found, page 1 of 1

ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

Allergen immunotherapy (AIT), the gradually increasing repeated administration of high doses of allergens to allergic patients, offers the potential for immune tolerance against reactions to the natural exposures to specific allergens. AIT may lead to the long‐lasting remission of allergic symptoms and is the only disease‐modifying intervention in IgE‐mediated allergic respiratory diseases. [...]

ARIA digital anamorphosis: Digital transformation of health and care in airway ...

Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validate...

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: ...

In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impa...

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: ...

In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Imp...

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: ...

We would like to thank the following companies for their unrestricted educational grants: Mylan, ALK, GSK, Novartis, Sanofi, Stallergenes-Greer, Uriach.

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: ...